期刊文献+

基质金属蛋白酶2及其抑制因子2在子宫腺肌病中的表达及意义 被引量:1

Expression and significance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in adenomyosis
原文传递
导出
摘要 目的 探讨基质金属蛋白酶2(MMP-2)及其抑制因子2(TIMP-2)在子宫腺肌病(AM)在位内膜与异位内膜的表达及意义.方法 选取广州医学院附属广州市第一人民医院2006年2月至2007年9月因AM行全子宫切除术的42例病例(取其在位及异位内膜分为AM在位内膜组和AM异位内膜组)和同期因子宫肌瘤在该院行全子宫切除术的32例病例(取其内膜作为正常子宫内膜组),应用半定量反转录聚合酶链反应(RT-PCR)检测AM在位内膜、异位内膜及正常子宫内膜中MMP-2、TIMP-2mRNA的表达.结果 (1)MMP-2 mRNA在AM异位内膜组中相对表达量(1.43±0.32)高于AM在位内膜组和正常子宫内膜组(1.22±0.35,0.97±0.37,P<0.05).TIMP-2 mRNA在AM异位内膜组和AM在位内膜组中均低表达,其相对表达量分别低于正常子宫内膜组(0.96±0.31,1.13±0.30,1.29±0.19,P<0.05).(2)MMP-2 mRNA、TIMP-2 mRNA在子宫腺肌病在位内膜组、正常子宫内膜组的表达有周期性,分泌期均高于增生期(P<0.05);而在AM异位内膜组中,两者分泌期与增生期则差异无统计学意义.(3)MMP-2/TIMP-2的比值在AM异位内膜组、AM在位内膜组、正常子宫内膜组中依次递减,其中AM异位内膜组与后两组差异有统计学意义(均P<0.05).结论 AM异位和在位内膜组织中MMP-2高表达,TIMP-2低表达,使MMP-2/TIMP-2平衡失调,异位内膜组织侵袭降解细胞外基质的能力增强. Objective To investigate the expression and significance of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) in ectopic and eutopic endometrium in adenomyosis. Methods Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the mRNA of MMP-2 and TIMP-2 in ectopic and eutopic endometrium from 42 patients who received panhysterectomy for adenomyosis (AM ectopic group and AM eutopic group), and in eutopic endometrium from 32 who received panhysterectomy for uterine myoma (normal control group), in The First Municipal People's Hospital of Guangzhou from February 2006 to September 2007. Results ①The relative expression level of MMP-2 mRNA in AM ectopic endometrium group (1.43±0.32) was significantly higher than that in normal group (1.22±0.35) and AM eutopic group (0.97±0.37) (P〈0.05), whereas the relative expression level of TIMP-2 mRNA in both AM ectopic and eutopic groups (0.96±0.31 and 1.13±0.30) was significantly lower than that in the normal control group (1.29±0.19, P〈0.05). ②The expression of MMP-2 and TIMP-2 showed phase-dependent changes in the eutopic endometrium, with higher level in secretory phase than in proliferative phase (P〈0.05). However, in ectopic endometrium, the expression was statistically similar in both phases (P〉0.05). ③The highest ratio of MMP-2/TIMP-2 was in ectopic endometrium, and the lowest in normal endometrium, with significant difference comparing the AM ectopic group to AM eutopic group and normal control group. Conclusion High expression of MMP-2 and low expression of TIMP-2 are found in ectopic and eutopic endometrium from AM patients. The MMP-2/TIMP-2 dysequilibrium in ectopic endometrium may underlie its enhanced activity for invasion and degradation of extracellular matrix
出处 《中华生物医学工程杂志》 CAS 2010年第6期522-525,共4页 Chinese Journal of Biomedical Engineering
基金 广东省科学技术厅基金项目(2006835930003)
关键词 基质金属蛋白酶2 基质金属蛋白酶抑制因子2 子宫内膜 子宫腺肌病 反转录聚合酶链反应 Matrix metalloproteinase-2 Tissue inhibitor of metalloproteinase-2 Endometrium Adenomyosis Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献9

  • 1Matsuda M, Sasabe H, Adachi Y, et al. Increased invasion activity of endometrial stromal cells and elevated expression ofmatrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis. Am J ObstetGyneeol, 2001, 185: 1374-1380.
  • 2Chung HW, Lee JY, Moon HS, et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase and tissue inhibitor ofmetalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril, 2002, 78: 787-795.
  • 3Li T, Li YG, Pu DM. Matrix metalloproteinase- 2 and -9expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest, 2006, 62: 229-255.
  • 4Waas ET, Hendriks T, Lomme RM, et al. Plasma levels of matrix metalloprotcinase- 2 and tissue inhibitor of metalloproteinase- 1correlate with disease stage and survival in eolorectal cancer patients. Dis Colon Rectum, 2005, 48: 700-710.
  • 5Boyd RS, Balkwill FR. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br J Cancer, 1999, 80:315-321.
  • 6Vander Linden PJ, Degoeij AF, Dunselman GA, et al. Endometfial cell adhesion in an in vitro model using amniotic membranes. FertilSteril, 1996, 65: 76-80.
  • 7康佳丽,李莉,杜洪,夏薇,王小霞.基质金属蛋白酶-7及其抑制因子-1在子宫腺肌病中的表达及意义[J].中华妇幼临床医学杂志(电子版),2006,2(3):134-136. 被引量:6
  • 8夏玉芳,娄艳辉,于云鹏,郭新华.MMP-2、TIMP-2及VEGF蛋白在子宫内膜异位症裸鼠模型组织中的表达及意义[J].青岛大学医学院学报,2007,43(4):313-315. 被引量:6
  • 9Ezaki K, Motoyama H, Sasaki H. hnmunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol, 2001, 98: 815-819.

二级参考文献10

  • 1娄艳辉,钱金花,郭新华.MMP-1及TIMP-1在异位内膜组织中的表达[J].齐鲁医学杂志,2004,19(5):392-393. 被引量:6
  • 2WITZ C A,THOMAS M R,MONTOYA-RODRIGUEZ I A,et al.Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium[J].Fertil Steril,2001,75(2):385-390.
  • 3VAN DER LINDEN P J,DE GOEIJ A F,DUNSELMAN G A,et al.Endometrial cell adension in an in vitro model using amniotic membranes[J].Fertil Steril,1996,65(1):76-80.
  • 4UEDA M,YAMASHITA Y,TAKEHARA M,et al.Gene expression of adhension molecules and matrix metalloproteinases in endometriosis[J].Gynecol Endocrinol,2002,16(5):391-402.
  • 5CHUNG H W,LEE J Y,MOON H S,et al.Matrix metalloproteinase-2,membranous type 1 matrix metalloproteinase,and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium[J].Fertile Steril,2002,78(4):787-795.
  • 6HYDER S M,STANCEL G M.Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins[J].Mol Endo,1999,13(6):806-811.
  • 7赵亮,尚涛,王雁玲,唐爽.金属基质蛋白酶-26在妊娠早期和中期原代细胞滋养细胞中的表达[J]中华妇产科杂志,2004(02).
  • 8齐璇,辛晓燕,常吉庆,王德堂,郭会玲.基质金属蛋白酶-2、血管内皮生长因子在子宫内膜异位症中的表达及意义[J].肿瘤防治研究,2003,30(1):15-15. 被引量:5
  • 9王滨,郑维国,辛晓燕,王德堂,郭会玲,于月成.HSP70与FasL在子宫内膜异位症中的表达[J].现代妇产科进展,2003,12(4):264-266. 被引量:3
  • 10郎景和.子宫内膜异位症的研究与设想[J].中华妇产科杂志,2003,38(8):478-480. 被引量:527

共引文献10

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部